公司資料
Bolt Biotherapeutics 股價、新聞與催化劑
- 股票代碼:
- BOLT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.20 USD (-4.48%)
收盤價
最後更新: 2026年8月17日
9.82M USD
市值
股價為何變動
As of Aug 17, 2026, BOLT closed down 4.48% at $3.20. No new same-company headline was identified in the current news window.
公司概覽
Immune-Stimulating Antibody Conjugates
Bolt Biotherapeutics develops Boltbody immune-stimulating antibody conjugates that combine tumor targeting with activation of innate and adaptive immunity.
BDC-4182
BDC-4182 targets claudin 18.2 and is being evaluated in gastric, gastroesophageal junction, pancreatic, and other solid tumors.
Mechanistic Positioning
The program is designed to combine antibody-drug conjugate-like precision with durable immune activation associated with T-cell-engaging therapies.
未來催化劑
- Initial Phase 1/2 BDC-4182 clinical data in gastric and gastroesophageal cancers are expected in the third quarter of 2026.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。